BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2017
View Archived Issues
Assembly Biosciences selects second CpAM candidate for clinical development
Read More
Medicago begins phase III study of quadrivalent influenza vaccine candidate
Read More
Glythera obtains license to CDK11 inhibitor program from Cancer Research UK
Read More
Ascendis Pharma begins dosing in phase I study of TransCon PTH
Read More
Alnylam Pharmaceuticals begins phase II study of cemdisiran in aHUS
Read More
Launch of SpringWorks Therapeutics
Read More
Novel MABA bronchodilator CHF-6366 evaluated in vitro and in vivo
Read More
Hanmi presents data on HM-15136 for CHI treatment
Read More
Immune Pharmaceuticals gives update on phase II study of bertilimumab in severe bullous pemphigoid
Read More
Bavencio approved in Japan for Merkel cell carcinoma
Read More
SCORES study finds benefit to combining anti-PD-L1 antibody with AZD-9150 in head and neck cancer
Read More
FDA grants rare pediatric disease and fast track designations to Audentes' AT-132
Read More
First patient treated in phase II study of Genelux's GL-ONC1 in ovarian cancer
Read More
TNT-009 shows promise for the treatment of transplant rejection
Read More
Vichem Chemie Research patents FGFR inhibitors
Read More
AC Immune divulges SNCA-targeting compounds for PET imaging
Read More
Bio-Pharm Solutions presents carbamate derivatives
Read More
IRE1A inhibitors described in Cornell University patent
Read More
CTxT Pty divulges PRMT5 inhibitors
Read More
FDA issues complete response letter for Intarcia's ITCA-650
Read More
HSP90 inhibitor TAS-116 displays activity and manageable toxicity in phase II GIST trial
Read More
Synairgen reports new analysis of phase II INEXAS study of SNG-001 in asthma patients
Read More
Novartis and UC Berkeley form alliance to unlock undruggable disease targets
Read More
MSD receives approval in Japan for Ziplava to avoid recurrent C. difficile infection
Read More
MSD announces approval of Atozet Tablets in Japan
Read More
Board recommends continuation of phase III study of CardiAMP stem cell therapy for heart failure
Read More
NeRRe Therapeutics launches KaNDy Therapeutics
Read More
Lexicon Pharmaceuticals starts dosing in phase I study of LX-9211
Read More
European Commission approves Dupixent for atopic dermatitis
Read More